Loss of SETD2 is associated with dysregulation of protein translation in clear cell renal cell carcinoma

Robert Hapke, Katherine E. Beckermann MD/PhD,
W. Kimryn Rathmell MD/PhD, and Scott M. Haake MD
Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center presents Loss of SETD2 is associated with dysregulation of protein translation in clear cell renal cell carcinoma.

Filmed at the 18th International Kidney Cancer Symposium 2019, Miami, FL.